Euglena Co Ltd
TSE:2931
Euglena Co Ltd
Operating Income
Euglena Co Ltd
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Euglena Co Ltd
TSE:2931
|
Operating Income
-¥1.5B
|
CAGR 3-Years
9%
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
|
Shiseido Co Ltd
TSE:4911
|
Operating Income
¥19.3B
|
CAGR 3-Years
9%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
-9%
|
|
Rohto Pharmaceutical Co Ltd
TSE:4527
|
Operating Income
¥40.6B
|
CAGR 3-Years
25%
|
CAGR 5-Years
14%
|
CAGR 10-Years
9%
|
|
Pola Orbis Holdings Inc
TSE:4927
|
Operating Income
¥16.1B
|
CAGR 3-Years
5%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
0%
|
|
Kao Corp
TSE:4452
|
Operating Income
¥86.6B
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-4%
|
|
Kobayashi Pharmaceutical Co Ltd
TSE:4967
|
Operating Income
¥25.8B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
4%
|
See Also
What is Euglena Co Ltd's Operating Income?
Operating Income
-1.5B
JPY
Based on the financial report for Dec 31, 2023, Euglena Co Ltd's Operating Income amounts to -1.5B JPY.
What is Euglena Co Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
28%
Over the last year, the Operating Income growth was 58%. The average annual Operating Income growth rates for Euglena Co Ltd have been 9% over the past three years , 28% over the past five years .